|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and safety of tofacitinib,an oral Janus kinase inhibitor,in the treatment of psoriasis:a Phase 2b randomized placebo-controlled dose-ranging study显示文摘 | Papp K Menter A Strober B | 2012 | Br J Dermatol2012，167，3： | 1 |
| 2 | The progression of burn depth in experimental burns:a histological and methodological study显示文摘 | Papp A Kiraly K Harma M | 2004 | Burns2004，30，7： | 1 |
| 3 | Elevated ex pression of matrix metalloproteinase 9, and fibronectin concen tration in recurrent epithelial ovarian cancer显示文摘 | Demeter A Szirmai K Olah J Papp Z Jeney A | 2004 | Orv Hetil2004，145，： | 1 |
| 4 | Oral apremilast is active in the treatment of moderate to severe plaque psoriasis: results from a phase 2b, randomized, controlled study (PSOR- 005) 显示文摘 | Papp K Hu A Day R | 2011 | JlnvestDermatol2011，131，： | 1 |
| 5 | Efficacy and safety of secukinumab in the treatment of moderate - to - severe plaque psoriasis : a randomized, double - blind, placebo - controlled phase Ⅱ dose - ran- ging study显示文摘 | Papp K A Langley R G Sigurgeirsson B | 2013 | British Journal Dermatology2013，168，： | 1 |
| 6 | Etanercept and clinical out- comes, fatigue, and depression in psoriasis: double-blind place- bo-controlled randomised phase Ⅲ trial显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 7 | Physically constrained maximum likelihood mode filtering显示文摘 | Papp J C Preisig J C Morozov A K | 2010 | The Journal of the Acoustical Society of America2010，127，4： | 1 |
| 8 | Etanercept and clini-cal outcomes,fatigue,and depression in psoriasis:dou-ble-blind placebo-controlled randomised phaseⅢtrial显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 9 | A rando-mized,double-blind,placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis显示文摘 | KRUEGER G G PAPP K A STOUGH D B | 2002 | J Am Acad Dermatol2002，47，6： | 1 |
| 10 | Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial 显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 11 | The progression of burn depth in experimental burns:a histological and methodological study显示文摘 | Papp A Kiraly K Harma M | 2004 | Burns2004，30，7： | 1 |
| 12 | Etanercept and clinical outcomes,fatigue,and depression in psoriasis:double-blind placebo-controlledrandomised phase IHtrial显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 13 | Time course of the protection against ischaemia and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing显示文摘 | Kaszala K Vegh A Papp J G | 1996 | JOURNAL O[MOLECULAR AND CELLULAR CARDIOLOGY1996，28，10： | 1 |
| 14 | Long - term safety of usteki- numab in patients with moderate - to - severe psoriasis: final results from 5 years of follow - up 显示文摘 | Papp K A Griffiths C E Gordon K | 2013 | The British journal of dermatology2013，168，： | 1 |
| 15 | Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised,double-blind, placebo-controlled trial ( PHOENIX 1 ) 显示文摘 | Leonardi C L Kimball A B Papp K A | 2008 | Lancet2008，371，9625： | 1 |
| 16 | Etanercept and clinical outcomes,fatigue,and depression in psoriasis:double-blind placebo-controlled randomised phase Ⅲ trial 显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 17 | Cholesteryl Ester transfer protein (CETP) polymorphisms affect mRNA splicing, HDL levels,and sex-dependent cardiovascular risk显示文摘 | Papp A C Pinsonneault J K Wang D X | 2012 | PloS one2012，7，31： | 1 |
| 18 | Etanercept andclinical outcomes, fatigue, and depression in psoriasis : double-blind placebo-controlled randomised phase III trial 显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
| 19 | Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study显示文摘 | Papp K A Langley R G Sigurgeirsson B | 2013 | Br J Dermatol2013，168，2： | 1 |
| 20 | Etanercept and clinicaloutcomes, fatigue, and depression in psoriasis: double-blindplacebocontrolled randomised phase III trial 显示文摘 | Tyring S Gottlieb A Papp K | 2006 | Lancet2006，367，9504： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员